Jean Jacques Patard

Papers

Total Citations

2,259

H-Index

About

Jean Jacques Patard is a leading figure in urologic oncology, whose work has fundamentally shaped the clinical management of renal cell carcinoma (RCC). His primary research areas encompass the surgical treatment of kidney cancer, prognostic factor analysis, and the development of evidence-based clinical guidelines. Patard’s most significant contribution is his leadership in authoring the ESMO Clinical Practice Guidelines for RCC, a seminal paper with over 2,200 citations that has served as the global standard for diagnosis, treatment, and follow-up. Beyond this landmark work, he has been instrumental in advancing the understanding of nephron-sparing surgery and the role of cytoreductive nephrectomy in the era of targeted therapies. His research portfolio, which includes numerous high-impact studies on tumor biology and surgical outcomes, has directly influenced how clinicians stage and treat this disease. Patard’s ability to translate complex clinical data into actionable protocols has made him a trusted voice in oncology, and his guidelines remain essential reading for any practitioner or researcher working in kidney cancer.